Survival benefit of coronary-artery bypass grafting accounted for deaths in those who remained untreated by Sobolev, Boris G et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
Journal of Cardiothoracic Surgery
Open Access Research article
Survival benefit of coronary-artery bypass grafting accounted for 
deaths in those who remained untreated
Boris G Sobolev*1, Guy Fradet2, Robert Hayden3, Lisa Kuramoto4, 
Adrian R Levy1 and Mark J FitzGerald4
Address: 1Department of Health Care and Epidemiology, The University of British Columbia, Canada, 2Department of Surgery, The University of 
British Columbia, Canada, 3Department of Surgery, Royal Columbian Hospital, New Westminster, Canada and 4Centre for Clinical Epidemiology 
and Evaluation, Vancouver Coastal Health Research Institute, Canada
Email: Boris G Sobolev* - sobolev@interchange.ubc.ca; Guy Fradet - gfradet@telus.net; Robert Hayden - erh@telus.net; 
Lisa Kuramoto - lisa.kuramoto@vch.ca; Adrian R Levy - alevy@cheos.ubc.ca; Mark J FitzGerald - mark.fitzgerald@vch.ca
* Corresponding author    
Abstract
Background:  Currently there are no direct estimates of mortality reduction afforded by
coronary-artery bypass grafting (CABG) that take into account the deaths among patients for
whom coronary revascularization was indicated but who did not undergo the treatment. The
objective of this analysis was to compare survival after the treatment decision between patients
who underwent CABG and those who remained untreated.
Methods: We used a population-based registry to identify patients with established coronary
artery disease who were to undergo first-time isolated CABG. We measured the effect of surgical
revascularization on survival after the treatment decision in two cohorts of patients categorized by
symptoms, coronary anatomy, and left ventricular function.
Results: One in 10 patients died during the five years after treatment decision. The hazard of death
among patients who underwent CABG was 51 percent of that for the untreated group, the
adjusted hazard ratio was 0.51 (95 percent confidence interval, 0.43 to 0.61). The effect was
stronger when CABG was performed within the recommended time: adjusted hazard ratios were
0.43 (95 percent confidence interval, 0.35 to 0.53) and 0.58 (95 percent confidence interval, 0.48
to 0.70) for early and late intervention, respectively; chi-square for the difference between hazard
ratios was 12.2 (P < 0.001).
Conclusion: Estimates that account for patients who died before they could undergo a required
CABG indicate a significant survival benefit of performing early surgical revascularization even for
patients registered to undergo the operation on the non-urgent basis.
Introduction
Randomized trials and observational studies have dem-
onstrated survival benefits conferred by coronary-artery
bypass grafting (CABG) [1]. The intervention has been
shown to improve long-term survival in stable sympto-
matic patients with left main coronary disease, triple-ves-
sel disease, or two-vessel disease with significant stenosis
of the proximal left anterior descending coronary artery
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[2]. In practice, however, personal reasons, scheduling
procedures, or surgical wait lists can delay CABG after
decision to operate has been made [3]. Hannan et al.
argued that estimates of survival benefits conferred by
CABG should account for the total number of deaths
including deaths resulting from delays for required revas-
cularization [4]. We anticipate that such estimates can
show the difference in the risk of death between patients
who actually undergo required CABG and those who
remain untreated after the decision to treat has been
made. The purpose of this analysis was to compare sur-
vival after the treatment decision between patients who
underwent CABG and those who remained untreated. We
used observational data from a population-based registry
of patients with established coronary artery disease for
whom surgical revascularization was indicated and
planned. That registry collects information about adverse
events on wait lists during the pre-operative period. There-
fore it allows us to compare prognosis for both alterna-
tives: if CABG is performed or if the patient remains
untreated. In our view, such estimates introduce a meth-
odological innovation, whereby deaths among untreated
patients are used to estimate the risk of death for the
treated group if they had remained untreated.
Methods
Data sources
Data were obtained from the British Columbia Cardiac
Registry (BCCR). This prospective database contains dates
of registration, procedure, and withdrawal, along with dis-
ease severity and other risk factors, for all patients who
have been registered to undergo CABG in any of the 4 ter-
tiary hospitals that provide cardiac care to adult residents
of British Columbia, Canada, since 1991 [5]. To identify
hospital admission and discharge dates, coexisting condi-
tions, and in-hospital deaths, we used patients' Provincial
Health Number to link deterministically BCCR records to
the British Columbia Linked Health Database Hospital
Separations File [6]. Data on coexisting conditions were
retrieved in the form of diagnoses reported in discharge
abstracts created during the calendar year before the treat-
ment decision [7]. To identify deaths that did not occur in
a hospital, we linked the BCCR to the British Columbia
Linked Health Database Deaths File [8]. The University of
British Columbia Ethics Board approved the study.
Participants and outcomes
Our inception cohort consisted of all adult British Colum-
bia residents with established coronary artery disease and
a recorded request from a cardiac surgeon to book an
operating room for isolated CABG in one of the participat-
ing hospitals between January 1, 1991, and December 31,
2000. We restricted the study to patients who required
treatment on a semi-urgent or non-urgent basis and who
had not previously undergone CABG (see Table 1 for cri-
teria). We excluded 54 records that contained either insuf-
ficient information or invalid data: the registration and
procedure dates were identical (50) or there was no surgi-
cal report (4). We excluded an additional 220 records for
which registration and admission date suggested that the
procedure had been performed immediately (115) or the
request for the operating room had been sent and subse-
quently withdrawn several times (105). The study cohort
thus consisted of 8,220 patients registered to undergo
first-time isolated CABG.
The primary outcome was death from any cause after the
decision for surgery had been made. The follow-up time
was counted as the number of months from the decision
to treat until death, which may occur before surgery, after
surgery but during the same hospital admission [10], and
after discharge from the hospital, or a censoring event,
whichever came first. Censoring events included removal
from wait list due to being operated elsewhere, five years
after the treatment decision (due to data availability), or
December 31, 2002. The date of the surgeon's request to
book the operating room served as the date of the decision
for surgery and registration on a wait list. In British
Columbia, surgical wait lists hold patient names until the
surgery can be scheduled [9]. Patients are removed from a
wait list without surgery if they die, if they reconsider the
decision to undergo surgery, if their condition deteriorates
such that surgery is no longer possible, or if they undergo
surgery elsewhere.
Table 1: Definition of study groups
Group Target Time for Surgery Anginal Symptoms, Coronary Anatomy, and Left Ventricular Function
Semi-urgent Within 6 weeks Patients with either persistent unstable angina or stable angina and extensive CAD* (left-main stenosis 
more than 50 percent, triple-vessel disease, or double-vessel disease with significant proximal left anterior 
descending stenosis and impaired left ventricular function)
Non-urgent Within 12 weeks Stable symptomatic patients with limited CAD (double-vessel disease with no lesion in the proximal left 
anterior descending artery and normal left ventricular function or single-vessel disease with significant 
stenosis of the proximal left anterior descending artery)
*CAD = coronary artery disease.
Target Time = Recommended timeJournal of Cardiothoracic Surgery 2008, 3:47 http://www.cardiothoracicsurgery.org/content/3/1/47
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In a separate analysis, we also studied deaths that occurred
after discharge from the hospital. The follow-up time for
patients who underwent surgery and were alive at dis-
charge was counted as the number of months from dis-
charge to death or 5 years or December 31, 2002,
whichever came first. We excluded an additional 66
records from the analysis of long-term post-operative sur-
vival because the discharge date was invalid or missing.
Statistical analysis
The average mortality rate – that is, the total number of
deaths divided by the total number of patient-months at
risk – was calculated for the study groups. Patients con-
tributed time at risk to the untreated group until treat-
ment, after which they contributed remaining time at risk
to the treated group [11]. To measure the treatment-
related effect, we used Cox regression with a time-depend-
ent indicator variable that changed from 0 to 1 after sur-
gery [12]. The exponential of the regression coefficient for
this variable gave the hazard ratio for treated patients rel-
ative to those who remained untreated, a value of less
than 1 indicating a lower hazard resulting from having
undergone CABG. Such an approach allowed us to repre-
sent changes in the group membership (treated vs.
untreated) over the follow-up time. The calculation
assumes the ratio of hazards between groups is constant,
whereas the hazard of death may evolve over time in each
group.
We also studied whether survival differed significantly
among patients who waited for CABG longer than the rec-
ommended time (6 weeks for patients in the semi-urgent
group and 12 weeks for those in the non-urgent group
[9]), using a separate model with two time-dependent
indicator variables for CABG performed before and after
the recommended time. To test for differences in post-
operative survival between patients who underwent
CABG within and after the recommended time, we used
Cox regression with fixed covariates [13]. The timing of
surgery was an indicator variable, a value of 1 denoting
CABG within the recommended time. Point estimates and
confidence intervals for hazard ratios were calculated for
each urgency group and for the entire cohort.
We used multivariate models to control for differences in
patients' characteristics and significant confounders (sum-
marized in Table 2). In particular, we entered two indica-
tor variables for the following categories of co-existing
medical conditions: congestive heart failure, diabetes mel-
litus, chronic obstructive pulmonary disease, cancer, or
rheumatoid arthritis [14]; and other co-existing chronic
conditions listed in a clinical comorbidity index that was
adapted for administrative data [15]. Presentation with-
out co-existing conditions was the reference category.
When performing the Cox regression analysis we stratified
by age and sex to avoid the proportionality assumption
for these variables. To assess whether the estimated mod-
els were consistent with our data we used the likelihood
ratio test. All analyses were conducted with SAS version
8.2.
Results
Access to surgery
Table 2 shows the baseline characteristics of the study
cohort by access to surgery. Of the 8,220 patients regis-
tered for first-time isolated CABG, 7,316 (89.0 percent)
underwent surgery, and 904 (11.0 percent) remained
untreated because they died while awaiting CABG (80 or
1.0 percent), withdrew from treatment because they
reconsidered the decision to undergo surgery, their condi-
tion deteriorated such that surgery was no longer possible
or for other reasons (716 or 8.7 percent), or were lost to
follow-up before the operation (108 or 1.3 percent). The
median time from registration to surgery was 12 weeks
(interquartile range, 6 to 23 weeks). Of patients in the
semi-urgent group, 1,986 (31.4 percent) underwent elec-
tive CABG within the recommended time, 3,599 (56.8
percent) underwent elective CABG but after the recom-
mended time, and 207 (3.3 percent) underwent the pro-
cedure via unplanned emergency admission. Among
those in the non-urgent group, 538 (28.5 percent) under-
went elective CABG within the recommended time, 927
(49.1 percent) underwent elective CABG but after the rec-
ommended time, and 59 (3.1 percent) underwent the
procedure via unplanned emergency admission.
Survival after treatment decision
One in 10 patients died during the first five years after the
treatment decision: 80 while awaiting surgery, 141 after
withdrawal from surgical treatment, 97 post-operatively
during the admission for CABG, and 551 after hospital
discharge (Table 3). The mean follow-up time after the
treatment decision was 4.3 (standard error 0.02) years in
the semi-urgent group and 4.3 (0.03) years in the non-
urgent group.
Surgical revascularization significantly reduced mortality
in the study cohort. The observed mortality rate was 1.7
deaths per 1000 patient-months in the treated patients
and 4.0 deaths per 1000 patient-months in the untreated
patients. The mortality rate was 1.5 and 1.8 deaths per
1000 patient-months for early (within the recommended
time) and late (longer than the recommended time) treat-
ment, respectively.
Among those who underwent CABG, the hazard of death
was 51 percent of that in the untreated group, the adjusted
hazard ratio 0.51 (95 percent confidence interval, 0.43 to
0.61) (Table 4). The effect was stronger when CABG was
performed within the recommended time: the adjustedJournal of Cardiothoracic Surgery 2008, 3:47 http://www.cardiothoracicsurgery.org/content/3/1/47
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hazard ratios were 0.43 (95 percent confidence interval,
0.35 to 0.53) and 0.58 (95 percent confidence interval,
0.48 to 0.70) for early and late treatment, respectively
(Wald chi-square = 12.2, df = 1, P < 0.001). The effect sizes
for early and late treatment and the difference between
them remained unchanged when an additional variable
for undergoing CABG through unplanned emergency
admission was entered into the regression model. In all
models listed in Table 4, patients in the semi-urgent group
were at a higher hazard of death than those in the non-
urgent group, the adjusted hazard ratio ranging from 1.25
(95 percent confidence interval, 1.04 to 1.50) to 1.27 (95
percent confidence interval, 1.05 to 1.53). The full model
was consistent with the data (likelihood ratio test = 148.9,
df = 10, P < 0.001).
The survival benefit differed between urgency groups. For
semi-urgent patients the mortality rates in the treated and
Table 2: Characteristics of patients in the study cohort by access to surgery after registration for CABG (as number and percentages 
across each characteristic)
Access to surgery, % in each category
Characteristic % of all patients
(N = 8220)
Unplanned emergency
(N = 266)
Elective within target time
(N = 2524)
Elective after target time
(N = 4526)
Remained untreated
(N = 904)
Age
< 50 yr 666 (8.1) 19 (2.9) 209 (31.4) 370 (55.6) 68 (10.2)
50–59 yr 1814 (22.1) 55 (3.0) 518 (28.6) 1054 (58.1) 187 (10.3)
60–69 yr 3125 (38.0) 104 (3.3) 962 (30.8) 1727 (55.3) 332 (10.6)
70–79 yr 2457 (29.9) 84 (3.4) 787 (32.0) 1307 (53.2) 279 (11.4)
≥ 80 yr 158 (1.9) 4 (2.5) 48 (30.4) 68 (43.0) 38 (24.1)
Sex
Female 1453 (17.7) 62 (4.3) 440 (30.3) 771 (53.1) 180 (12.4)
Male 6767 (82.3) 204 (3.0) 2084 (30.8) 3755 (55.5) 724 (10.7)
Urgency group
Semi-urgent 6333 (77.0) 207 (3.3) 1986 (31.4) 3599 (56.8) 541 (8.5)
Non-urgent 1887 (23.0) 59 (3.1) 538 (28.5) 927 (49.1) 363 (19.2)
Comorbidity
Major conditions* 1756 (21.4) 68 (3.9) 564 (32.1) 897 (51.1) 227 (12.9)
Other conditions† 2113 (25.7) 79 (3.7) 735 (34.8) 1067 (50.5) 232 (11.0)
None 4351 (52.9) 119 (2.7) 1225 (28.2) 2562 (58.9) 445 (10.2)
Coronary anatomy
Left main 983 (12.0) 26 (2.6) 389 (39.6) 493 (50.2) 75 (7.6)
Multi-vessel‡ 6583 (80.1) 213 (3.2) 1932 (29.3) 3718 (56.5) 720 (10.9)
Limited§ 654 (8.0) 27 (4.1) 203 (31.0) 315 (48.2) 109 (16.7)
Period
1991–1992 1507 (18.3) 50 (3.3) 596 (39.5) 697 (46.3) 164 (10.9)
1993–1994 1716 (20.9) 51 (3.0) 654 (38.1) 833 (48.5) 178 (10.4)
1995–1996 1663 (20.2) 53 (3.2) 333 (20.0) 1090 (65.5) 187 (11.2)
1997–1998 1714 (20.9) 65 (3.8) 422 (24.6) 1021 (59.6) 206 (12.0)
1999–2000 1620 (19.7) 47 (2.9) 519 (32.0) 885 (54.6) 169 (10.4)
Hospital
1 1706 (20.8) 65 (3.8) 616 (36.1) 812 (47.6) 213 (12.5)
2 2759 (33.6) 74 (2.7) 964 (34.9) 1473 (53.4) 248 (9.0)
3 2013 (24.5) 58 (2.9) 372 (18.5) 1230 (61.1) 353 (17.5)
4 1742 (21.2) 69 (4.0) 572 (32.8) 1011 (58.0) 90 (5.2)
*Congestive heart failure, diabetes mellitus, chronic obstructive pulmonary disease, rheumatoid arthritis, cancer.
†Peripheral vascular disease, cerebrovascular disease, dementia, peptic ulcer disease, hemiplegia, renal disease, or liver disease.
‡Three- or two-vessel disease with stenosis of the proximal left anterior descending artery.
§Two-vessel disease with no lesion in the proximal left anterior descending artery or 1-vessel disease with stenosis of the proximal left anterior 
descending artery.
Target Time = Recommended timeJournal of Cardiothoracic Surgery 2008, 3:47 http://www.cardiothoracicsurgery.org/content/3/1/47
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untreated groups (1.8 and 4.6 per 1000 patient-months)
were higher than those for non-urgent patients (1.3 and
3.1 per 1000 patient-months). The rates were 1.6 and 1.9
deaths per 1000 patient-months in early and late treat-
ment groups of semi-urgent patients, and 1.1 and 1.4
deaths per 1000 patient-months respectively of non-
urgent patients.
Compared with untreated patients, the hazard of death
for those who underwent CABG was 46 percent lower in
the semi-urgent group and 55 percent lower in the non-
Table 3: Characteristics of patients in the study cohort by death after registration for CABG *(as number and percentages within each 
category for each characteristic)
Characteristic On wait lists 
(N = 80)
After withdrawal 
(N = 141)†
During admission 
(N = 97)
After discharge 
(N = 551)‡
Age
< 50 yr 5 (6.3) 5 (3.5) 2 (2.1) 15 (2.7)
50–59 yr 17 (21.3) 20 (14.2) 17 (17.5) 73 (13.2)
60–69 yr 29 (36.3) 38 (27.0) 35 (36.1) 196 (35.6)
70–79 yr 28 (35.0) 64 (45.4) 41 (42.3) 244 (44.3)
≥ 80 yr 1 (1.3) 14 (9.9) 2 (2.1) 23 (4.2)
Sex
Female 7 (8.8) 35 (24.8) 25 (25.8) 95 (17.2)
Male 73 (91.3) 106 (75.2) 72 (74.2) 456 (82.8)
Urgency group
Semi-urgent 54 (67.5) 98 (69.5) 86 (88.7) 456 (82.8)
Non-urgent 26 (32.5) 43 (30.5) 11 (11.3) 95 (17.2)
Comorbidity
Major conditions§ 26 (32.5) 53 (37.6) 32 (33.0) 176 (31.9)
Other conditions|| 20 (25.0) 36 (25.5) 23 (23.7) 130 (23.6)
None 34 (42.5) 52 (36.9) 42 (43.3) 245 (44.5)
Coronary anatomy
Left main 6 (7.5) 13 (9.2) 12 (12.4) 75 (13.6)
Multi-vessel¶ 66 (82.5) 112 (79.4) 81 (83.5) 447 (81.1)
Limited** 8 (10.0) 16 (11.3) 4 (4.1) 29 (5.3)
Period
1991–1992 13 (16.3) 22 (15.6) 26 (26.8) 145 (26.3)
1993–1994 23 (28.8) 27 (19.1) 14 (14.4) 114 (20.7)
1995–1996 18 (22.5) 39 (27.7) 22 (22.7) 131 (23.8)
1997–1998 17 (21.3) 33 (23.4) 21 (21.6) 113 (20.5)
1999–2000 9 (11.3) 20 (14.2) 14 (14.4) 48 (8.7)
Hospital
1 11 (13.8) 46 (32.6) 8 (8.2) 108 (19.6)
2 26 (32.5) 38 (27.0) 51 (52.6) 188 (34.1)
3 35 (43.8) 43 (30.5) 15 (15.5) 121 (22.0)
4 8 (10.0) 14 (9.9) 23 (23.7) 134 (24.3)
*Death on wait lists means any pre-operative death while on the wait list for surgery; death after withdrawal means any pre-operative death after 
removal from the wait list without surgery; death during admission means any death after surgery during the same hospital admission; death after 
discharge means any death after hospital discharge.
†Within 5 years after registration date.
‡Within 5 years after hospital discharge date, excluding two patients with unknown dates.
§Congestive heart failure, diabetes mellitus, chronic obstructive pulmonary disease, rheumatoid arthritis, cancer.
||Peripheral vascular disease, cerebrovascular disease, dementia, peptic ulcer disease, hemiplegia, renal disease, or liver disease.
¶Three- or two-vessel disease with stenosis of the proximal left anterior descending artery.
**Two-vessel disease with no lesion in the proximal left anterior descending artery or one-vessel disease with stenosis of the proximal left anterior 
descending artery.Journal of Cardiothoracic Surgery 2008, 3:47 http://www.cardiothoracicsurgery.org/content/3/1/47
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urgent group, and the adjusted hazard ratios were 0.54
(95 percent confidence interval, 0.44 to 0.66) and 0.45
(95 percent confidence interval, 0.32 to 0.63), respectively
(Table 5). In each group, patients waiting longer than the
recommended time were less likely than those with a
shorter delay to benefit from the treatment. However,
when CABG was performed after the recommended time,
the survival benefit appeared to be smaller in the semi-
urgent than the non-urgent group (adjusted hazard ratios
0.61 [95 percent confidence interval, 0.49 to 0.76] and
0.51 [95 percent confidence interval, 0.35 to 0.74], respec-
tively). Among patients in the non-urgent group, treat-
ment delay resulting in unplanned emergency admission
reduced the survival effect to a non-significant level
(adjusted hazard ratio 0.73 [95 percent confidence inter-
val, 0.33 to 1.63]). The regression models were consistent
with the data in both the semi-urgent group (likelihood
ratio test = 103.5, df = 9, P < 0.001) and the non-urgent
group (likelihood ratio test = 53.8, df = 9, P < 0.001).
Long-term post-operative survival
Among the 7,316 patients who underwent CABG, 97 (1.3
percent) died post-operatively during the same hospital
admission and 7,219 (98.7 percent) survived surgery. Of
those who was discharged alive 551 (7.6 percent) died
within five years. The observed death rate was 1.7 deaths
per 100 patient-years for those who underwent surgery
within the recommended time (184 deaths over 10,530
patient-years) and 2.1 deaths per 100 patient-years for
those whose surgery was delayed (367 deaths over 17,531
patient-years). After adjustment, those who underwent
CABG within the recommended time showed a 20 percent
lower hazard of post-operative death than patients whose
surgery was delayed (hazard ratio 0.80 [95 percent confi-
dence interval, 0.67 to 0.95]).
Delays in treatment had a different effect in each group
(Table 5). Among patients in the semi-urgent group (456
deaths over 22,292 patient-years), those who waited
longer than the recommended time were less likely than
those with a shorter delay to survive beyond five years.
The observed rate of post-operative death was 1.8 deaths
(95 percent confidence interval, 1.5 to 2.1) per 100
patient-years for those who underwent CABG within the
recommended time and 2.2 deaths (95 percent confi-
dence interval, 1.9 to 2.4) per 100 patient-years for those
whose surgery was delayed. After adjustment, those who
underwent CABG within the recommended time had a 21
percent lower hazard of late post-operative death than
those with delayed surgeries (hazard ratio 0.79 [95 per-
cent confidence interval, 0.65 to 0.96]). Among patients
in the non-urgent group (95 deaths over 5,769 patient-
years), the observed death rate was 1.5 deaths (95 percent
confidence interval, 0.9 to 2.0) per 100 patient-years in
those who underwent CABG during the recommended
time and 1.8 deaths (95 percent confidence interval, 1.3
to 2.2) per 100 patient-years in those whose surgery was
delayed. After adjustment, the effect of early surgery was
not significant (hazard ratio 0.86 [95 percent confidence
interval, 0.55 to 1.33]).
Discussion
In this cohort of 8,220 patients with angiographically-
proven coronary artery disease and planned surgical revas-
cularization, we compared survival between patients who
underwent CABG and those who remained untreated after
the decision to treat was made. We found that the hazard
Table 4: Hazard ratios (HRs) for death at any time after registration for CABG for treated patients relative to untreated patients and 
for patients who had surgery within target times relative to those who had surgery after target times
Time-dependent treatment effect* Unadjusted HR (95% CI) Adjusted HR(95% CI)†
Model I, Treatment indicator
Treated vs Untreated 0.53 (0.45–0.63) 0.51 (0.43–0.61)
Model II, Treatment indicators by target time
Early Surgery vs Untreated 0.46 (0.38–0.57) 0.43 (0.35–0.53)‡
Late Surgery vs Untreated 0.59 (0.49–0.71) 0.58 (0.48–0.70)‡
Model III, Treatment indicators by target time and admission type
Early Surgery vs Untreated 0.46 (0.37–0.57) 0.42 (0.34–0.52)§
Late Surgery vs Untreated 0.58 (0.48–0.71) 0.58 (0.48–0.70)§
Unplanned Emergency vs Untreated 0.59 (0.39–0.90) 0.56 (0.37–0.86)
*Among 8,220 patients who were registered to undergo CABG.
†CI denotes confidence interval.
‡Difference between regression estimates is significant (Wald chi-square = 12.2, df = 1, P < 0.001).
§Difference between regression estimates is significant (Wald chi-square = 12.3, df = 1, P < 0.001).
Target Time = Recommended time.Journal of Cardiothoracic Surgery 2008, 3:47 http://www.cardiothoracicsurgery.org/content/3/1/47
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of death among patients who underwent CABG was 51
percent of that in the untreated group (adjusted hazard
ratio 0.51 [95 percent confidence interval, 0.43 to 0.61]).
The effect was stronger when patients underwent surgery
shortly after the treatment decision (adjusted hazard
ratios 0.43 [95 percent confidence interval, 0.35 to 0.53]
and 0.58 [95 percent confidence interval, 0.48 to 0.70] for
early and late intervention, respectively). Relative to
untreated patients, the hazard of death for those who
underwent CABG was 46 percent lower in the semi-urgent
group and 55 percent lower in the non-urgent group
(adjusted hazard ratios 0.54 [95 percent confidence inter-
val, 0.44 to 0.66] and 0.45 [95 percent confidence inter-
val, 0.32 to 0.63], respectively).
CABG is indicated to alleviate symptoms and to reduce
the risk of death among patients who have limiting angina
that persists despite optimal medical treatment and suita-
ble coronary anatomy [1]. To fully evaluate the survival
benefit of CABG, the hazard of death for patients who
have undergone CABG should be compared with the haz-
ard of death for those who have not undergone the proce-
dure, considering the intervention as an intermediate
event in the course of disease. Because the group member-
ship (treated vs. untreated) cannot be defined at the
Table 5: Hazard Ratios for death at any time after registration for CABG for treated patients relative to untreated patients and for 
post-operative death for patients who had surgery within target times relative to those who had surgery after target times (figures in 
brackets are 95-percent confidence interval)
Semi-urgent group Non-urgent group
Overall survival, time-dependent treatment effect*
No. of deaths/no. of patients
Treated patients 517/5,792 95/1,524
Untreated patients 152/541 69/363
Model I, Treatment indicator
Treated vs Untreated
Unadjusted hazard ratio 0.53 (0.43–0.65) 0.42 (0.30–0.59)
Adjusted hazard ratio 0.54 (0.44–0.66) 0.45 (0.32–0.63)
Model II, Treatment by target time
Early Surgery vs Untreated
Unadjusted hazard ratio 0.47 (0.37–0.59) 0.35 (0.23–0.55)
Adjusted hazard ratio 0.45 (0.36–0.58) 0.36 (0.23–0.56)
Late Surgery vs Untreated
Unadjusted hazard ratio 0.58 (0.47–0.73) 0.47 (0.32–0.68)
Adjusted hazard ratio 0.61 (0.49–0.76) 0.51 (0.35–0.74)
Model III, Treatment by target time and admission type
Early Surgery vs Untreated
Unadjusted hazard ratio 0.47 (0.37–0.60) 0.32 (0.20–0.51)
Adjusted hazard ratio 0.45 (0.36–0.58) 0.33 (0.20–0.53)
Late Surgery vs Untreated
Unadjusted hazard ratio 0.58 (0.46–0.73) 0.46 (0.32–0.67)
Adjusted hazard ratio 0.61 (0.48–0.76) 0.51 (0.35–0.74)
Unplanned Emergency vs Untreated
Unadjusted hazard ratio 0.51 (0.31–0.84) 0.80 (0.37–1.76)
Adjusted hazard ratio 0.52 (0.32–0.87) 0.73 (0.33–1.63)
Long-term post-operative survival†
No. of deaths/follow-up yrs
Early Surgery 153/8,409 31/2,121
Late Surgery 303/13,883 64/3,648
Unadjusted hazard ratio 0.85 (0.70–1.03) 0.84 (0.55–1.29)
Adjusted hazard ratio 0.79 (0.65–0.96) 0.86 (0.55–1.33)
*Among 8,220 patients who were registered to undergo CABG.
†Within five years after discharge date among 7,153 patients who underwent surgery and did not die in hospital, after removal of 66 patients with 
invalid discharge dates
Target Time = Recommended timeJournal of Cardiothoracic Surgery 2008, 3:47 http://www.cardiothoracicsurgery.org/content/3/1/47
Page 8 of 9
(page number not for citation purposes)
beginning of follow-up, we accomplished this by using
the Cox regression with a time-dependent indicator varia-
ble for CABG occurrences during the follow-up period
after registration for the treatment. The hazard ratio for
that variable gives the estimated survival benefit, which a
patient for whom surgical revascularization is indicated
can interpret as the reduction in the risk of death offered
by undergoing CABG relative to remaining untreated.
Contrasting post-operative and pre-operative mortality
had two premises. The first was that excluding pre-opera-
tive deaths and losses to follow-up relating to a longer
wait for treatment would imply that survival time begins
at the time of the procedure, rather than at the time of the
decision to treat [3]. The second was that measuring mor-
tality reduction afforded by undergoing CABG requires an
allowance for the possibility that the patient undergoes
treatment and dies anyway.
In observational studies, death before CABG has been
reported to occur in 0.4 to 1.3 percent of patients for
whom it was felt that surgery could be safely delayed [16-
18]. Expressed in terms of group phenomena [19], these
percentages may be less relevant to the patient who is
more concerned with the fact that treatment delay may
result in otherwise avoidable deaths. The analysis pre-
sented in our paper, which concludes that undergoing
CABG rather than remaining untreated will reduce the risk
of death by half, is more relevant to patients because it
compares the 5-year prognosis for both alternatives: if
CABG is performed or if the patient remains untreated.
A meta-analysis of trials comparing CABG and medical
therapy showed that five-year mortality was 39 percent
lower among patients who underwent CABG [2], which is
similar to our findings for the semi-urgent group. The
more profound effect in the non-urgent group was due to
a 25 percent higher mortality rate for the semi-urgent
group independent of the intervention. However, the fact
that we considered all deaths among patients who had
never undergone CABG, including patients who became
not healthy enough to withstand the procedure or who
reconsidered the surgery for other reasons, might have
affected our estimates.
Our study was observational and therefore required risk
adjustment for potential differences between treated and
untreated patients. The existing literature suggests that
elderly patients are more likely to undergo revasculariza-
tion as an urgent procedure [20], that a smaller coronary
vessel diameter may account for the higher risk of adverse
cardiovascular events among women [21], that co-existing
medical conditions may delay open heart surgery [22],
that post-operative survival depends on institutional con-
straints and individual care providers [3], and that
changes in practice or supplementary funds may reduce
time until surgery [9]. All of these factors were entered
into multivariate regressions in our study. Still, we were
unable to adjust for upgrades in urgency during the pre-
operative period. Because increasing urgency reduced the
time to surgery, those who underwent CABG after an
urgency upgrade might have been more ill, which might
have resulted in a downward bias in the survival effect. On
the other hand, several studies have shown that, when
compared with medical charts, comorbid conditions are
underreported in administrative databases among per-
sons discharged after cardiovascular procedures [7,23,24].
Thus delayed surgery may be attributable to other
unmeasured factors, which might have resulted in a
upward bias in the survival effect for those unfit the oper-
ation. The quality of information about decision and
withdrawal dates is a concern in this analysis. Although
we considered the date of the booking request as the date
of the decision for surgery, no audit was conducted to ver-
ify the accuracy of the coding dates in the BCCR records.
Also, because we used only the British Columbia Linked
Health Database Deaths File, we did not have information
about patients who died or underwent CABG in other
provinces.
This study has provided estimates of mortality reduction
afforded by surgical revascularization, taking account of
patients who died before they could undergo a required
CABG. In particular, we found a significant survival bene-
fit for patients registered to undergo coronary revasculari-
zation on the non-urgent basis. The survival benefit of
CABG was greater when patients underwent the operation
within the recommended time, suggesting that some of
the benefit was lost by the delay beyond the recom-
mended time.
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